Experience with active vitamin D metabolites in phosphorus-calcium metabolic disorders in patients with predialysis chronic kidney disease

AIM: To evaluate the efficacy and safety of alfacalcidol and paracalcitol used to correct impaired phosphorus-calcium metabolism (PCM) in patients with predialysis chronic kidney disease (CKD)/MATERIAL AND METHODS: Examinations were made in 128 patients with Stages III-V CKD, including 89 (69.5%) pa...

Descrizione completa

Dettagli Bibliografici

Autori principali:	L Iu Milovanova, I A Dobrosmyslov, Iu S Milovanov
Natura:	Artigo
Lingua:	Russo
Pubblicazione:	"Consilium Medicum" Publishing house 2014-06-01
Serie:	Терапевтический архив
Soggetti:	chronic kidney disease phosphorus-calcium metabolic disorder paricalcitol alfacalcidol
Accesso online:	https://ter-arkhiv.ru/0040-3660/article/view/31500
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!